Abstract:Background & Objectives: Resveratrol has been reported as a potent anti-cancer compound, but it9s mode of action is not completely understood. In this study, we investigated the effects of resveratrol treatment on the activity and expression of antioxidant enzymes such as catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GPX) in three somatic cancer cell lines: PC-3 (prostate cancer), MCF-7 (breast cancer) and HepG2 (hepatocellular cancer). Methods: The cells were treated with different concentration (0-200 μM) of resveratrol for 24, 48 and 72 hours.Cell growth was studied by cell counting; cell homogenate was taken for the measurement of enzyme activities; proteins were isolated for western blotting to measure the genetic expression. Results: Resveratrol showed dose-dependent growth inhibitory activity in all cells. It was significantly effective against PC-3 and HepG2 even in 10 μM, and 25 μM concentration, but not in MCF-7 cells. However 50 μM showed significant growth inhibitory effect in MCF-7, and also in HEK293T (human embryonic kidney cell line as control) cells. 25 μM was identified as most effective dosage against PC-3 and HepG2 cells, without affecting HEK293T cells. Treatment of 25 μM for 48 hours increased the activity of SOD enzymes by 3-4 folds in PC-3; 2-3 folds in HepG2; 1.5-1.8 folds in MCF-7; and 1.2-1.5 folds in HEK293T cells. Resveratrol treatment also significantly increased the activity of CAT in HepG2, moderately in MCF-7, but non-significantly in PC-3 and HEK293T cells. However, the treatment of resveratrol showed no significant change in GPX activity in any cell line. Western blotting also revealed the increased expression of SOD2 in PC-3, and HepG2 cells at 25 μM resveratrol treatment. CAT expression was moderate, but no change in GPX1 expression was found in the tested cancer cells. Conclusions: The results of this study could confirm the dose dependent growth inhibitory potential of resveratrol; however, the dose of resveratrol in treatment of the cancer cells should be limited, as higher dose (Δ50 μM) has also been found dangerous for normal cells (HEK293T). Resveratrol at low dose (25 μM) potentially increases the activity and expression of SOD enzyme in cancer cells while inhibiting cell growth. Moderate increase of CAT activity and expression is also observed, but no significant change in GPX activity and expression in cell lines used in this study. These findings may contribute to understanding the mechanisms of resveratrol action in treatment of cancer. The work was supported by the National Basic Research Program of China (No. 2011CB910700-704) Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 1997. doi:1538-7445.AM2012-1997

Resveratrol Modifies The Activity And Expression Of Antioxidant Enzymes In Somatic Cancer Cells

Regulatory effects of resveratrol on antioxidant enzymes: A mechanism of growth inhibition and apoptosis induction in cancer cells

Modulation Of P-Glycoprotein, Cytochrome P450, And Glutathione-S-Transferase By Resveratrol In Human Cancer Cells

Resveratrol: an Overview of Its Anti-Cancer Mechanisms

Resveratrol Induces Gastric Cancer Cell Apoptosis Via Reactive Oxygen Species, but Independent of Sirtuin1.

Resveratrol Mediated Cancer Cell Apoptosis, and Modulation of Multidrug Resistance Proteins and Metabolic Enzymes.

Resveratrol and cancer treatment: updates

Resveratrol regulates cellular PKC alpha and delta to inhibit growth and induce apoptosis in gastric cancer cells

Regulation of Proliferation and Autophagy and Its Possible Mechanisms of Resveratrol on HepG2 Cells in Hypoxia

Resveratrol-induced cell inhibition of growth and apoptosis in MCF7 human breast cancer cells are associated with modulation of phosphorylated akt and caspase-9

Resveratrol inhibits proliferation, angiogenesis and induces apoptosis in colon cancer cells

Resveratrol Treatment Inhibits Proliferation of and Induces Apoptosis in Human Colon Cancer Cells

Resveratrol Inhibits Invasion and Metastasis of Hepatocellular Carcinoma Cells

A mechanistic insight into the anticancer potentials of resveratrol: Current perspectives

Resveratrol Suppresses Colon Cancer Growth by Targeting the AKT/STAT3 Signaling Pathway.

Resveratrol And Arsenic Trioxide Act Synergistically To Kill Tumor Cells In Vitro And In Vivo

Abstract 2744: Identification of Synergistic Effect of Autophagy Inhibitors and Resveratrol on BRCA1 Mutant Cancer Cells

Resveratrol inhibits the growth of gastric cancer by inducing G1 phase arrest and senescence in a Sirt1-dependent manner

Protective Effect of Resveratrol Against Non-Small Cell Lung Cancer: In-Vitro and In-Silico Studies

Resveratrol Inhibits Breast Cancer Stem-Like Cells and Induces Autophagy Via Suppressing Wnt/β-catenin Signaling Pathway.

Resveratrol, an activator of SIRT1, induces protective autophagy in non-small-cell lung cancer via inhibiting Akt/mTOR and activating p38-MAPK